Deerfield Management as of Sept. 30, 2016
Portfolio Holdings for Deerfield Management
Deerfield Management holds 90 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gw Pharmaceuticals Plc ads | 6.2 | $134M | 1.0M | 132.73 | |
| Portola Pharmaceuticals | 6.0 | $128M | 5.6M | 22.71 | |
| Horizon Pharma | 5.4 | $117M | 6.4M | 18.13 | |
| NxStage Medical | 4.8 | $102M | 4.1M | 24.99 | |
| Avexis | 4.3 | $92M | 2.2M | 41.21 | |
| Horizon Pharma Plc convertible security | 3.7 | $80M | 83M | 0.97 | |
| Healthways Inc note 1.500% 7/0 | 3.7 | $79M | 54M | 1.46 | |
| Adeptus Health Inc-class A | 3.2 | $69M | 1.6M | 43.05 | |
| Dbv Technologies S A (DBVT) | 3.0 | $63M | 1.7M | 36.33 | |
| Vanda Pharmaceuticals (VNDA) | 2.7 | $57M | 3.4M | 16.64 | |
| Nevro (NVRO) | 2.6 | $56M | 536k | 104.39 | |
| Xencor (XNCR) | 2.5 | $54M | 2.2M | 24.49 | |
| Mylan Nv | 2.5 | $54M | 1.4M | 38.12 | |
| Array Biopharma Inc note 3.000% 6/0 | 2.5 | $53M | 45M | 1.18 | |
| Flamel Technologies | 2.4 | $51M | 4.1M | 12.40 | |
| Aerie Pharmaceuticals | 2.4 | $51M | 1.3M | 37.74 | |
| Trn 4% 04/01/45 | 2.2 | $47M | 48M | 0.97 | |
| Wright Med Group Inc note 2.000% 2/1 | 2.0 | $43M | 40M | 1.07 | |
| Aetna | 2.0 | $42M | 366k | 115.45 | |
| Endologix Inc note 2.250%12/1 | 1.8 | $39M | 41M | 0.96 | |
| Aac Holdings | 1.8 | $38M | 2.2M | 17.39 | |
| Universal American | 1.6 | $35M | 4.6M | 7.65 | |
| Nivalis Therapeutics | 1.4 | $30M | 3.7M | 8.13 | |
| eHealth (EHTH) | 1.4 | $30M | 2.6M | 11.21 | |
| Walgreen Boots Alliance (WBA) | 1.3 | $29M | 356k | 80.62 | |
| Humana (HUM) | 1.3 | $28M | 160k | 176.89 | |
| Galapagos Nv- (GLPG) | 1.3 | $27M | 423k | 64.66 | |
| Syros Pharmaceuticals | 1.2 | $25M | 1.8M | 13.87 | |
| Audentes Therapeutics | 1.2 | $25M | 1.4M | 17.81 | |
| Tesaro | 1.1 | $24M | 242k | 100.24 | |
| DaVita (DVA) | 1.1 | $23M | 350k | 66.07 | |
| Editas Medicine (EDIT) | 1.1 | $23M | 1.7M | 13.48 | |
| Spark Therapeutics | 1.0 | $22M | 368k | 60.06 | |
| BioCryst Pharmaceuticals (BCRX) | 0.9 | $19M | 4.4M | 4.41 | |
| Glaukos (GKOS) | 0.9 | $19M | 503k | 37.74 | |
| Select Medical Holdings Corporation (SEM) | 0.8 | $18M | 1.4M | 13.50 | |
| Invuity | 0.8 | $18M | 1.3M | 13.72 | |
| Axogen (AXGN) | 0.8 | $17M | 1.9M | 9.03 | |
| Fluidigm Corporation convertible cor | 0.8 | $17M | 28M | 0.61 | |
| Five Prime Therapeutics | 0.8 | $16M | 311k | 52.49 | |
| Bluebird Bio (BLUE) | 0.7 | $15M | 224k | 67.78 | |
| Cytomx Therapeutics (CTMX) | 0.7 | $15M | 943k | 15.68 | |
| Proteon Therapeutics | 0.7 | $15M | 1.6M | 9.33 | |
| Foamix Pharmaceuticals | 0.6 | $12M | 1.3M | 9.26 | |
| Array BioPharma | 0.5 | $11M | 1.7M | 6.75 | |
| Akari Therapeutics | 0.5 | $9.8M | 1.2M | 8.51 | |
| Alimera Sciences | 0.4 | $8.8M | 5.9M | 1.49 | |
| Myokardia | 0.4 | $8.2M | 500k | 16.34 | |
| St. Jude Medical | 0.4 | $8.0M | 100k | 79.76 | |
| Ardelyx (ARDX) | 0.4 | $8.0M | 619k | 12.94 | |
| Axovant Sciences | 0.4 | $8.0M | 568k | 14.00 | |
| Aralez Pharmaceuticals | 0.4 | $8.0M | 1.6M | 4.85 | |
| EXACT Sciences Corporation (EXAS) | 0.3 | $6.6M | 358k | 18.57 | |
| Loxo Oncology | 0.3 | $6.6M | 251k | 26.18 | |
| Blueprint Medicines (BPMC) | 0.3 | $6.4M | 216k | 29.70 | |
| Steadymed | 0.3 | $6.3M | 1.8M | 3.59 | |
| Oxford Immunotec Global | 0.3 | $5.8M | 465k | 12.56 | |
| Essa Pharma | 0.3 | $5.8M | 2.1M | 2.75 | |
| BioScrip | 0.3 | $5.7M | 2.0M | 2.89 | |
| CAS Medical Systems | 0.3 | $5.5M | 3.2M | 1.73 | |
| Kempharm | 0.2 | $4.9M | 1.1M | 4.49 | |
| pSivida | 0.2 | $4.5M | 1.5M | 3.01 | |
| Nanostring Technologies (NSTGQ) | 0.2 | $4.5M | 227k | 19.98 | |
| Catabasis Pharmaceuticals | 0.2 | $4.2M | 683k | 6.16 | |
| Scynexis | 0.2 | $4.1M | 1.0M | 3.87 | |
| Global Blood Therapeutics In | 0.2 | $4.0M | 171k | 23.05 | |
| Molina Healthcare Inc conv | 0.2 | $3.6M | 3.0M | 1.19 | |
| Acorda Therapeutics | 0.2 | $3.4M | 162k | 20.88 | |
| Genocea Biosciences | 0.2 | $3.5M | 687k | 5.12 | |
| Exelixis (EXEL) | 0.1 | $3.2M | 247k | 12.79 | |
| Infinity Pharmaceuticals (INFIQ) | 0.1 | $3.0M | 1.9M | 1.56 | |
| Aclaris Therapeutics (ACRS) | 0.1 | $3.0M | 116k | 25.61 | |
| Epizyme | 0.1 | $2.9M | 291k | 9.84 | |
| Voyager Therapeutics (VYGR) | 0.1 | $2.8M | 235k | 12.01 | |
| Proteostasis Therapeutics In | 0.1 | $2.9M | 186k | 15.59 | |
| Trillium Therapeutics, Inc. Cmn | 0.1 | $2.5M | 172k | 14.78 | |
| Pronai Therapeutics | 0.1 | $2.5M | 1.4M | 1.82 | |
| Rite Aid Corporation | 0.1 | $2.1M | 275k | 7.69 | |
| Healthways | 0.1 | $2.0M | 76k | 26.46 | |
| Agile Therapeutics | 0.1 | $1.7M | 250k | 6.98 | |
| Acura Pharmaceuticals (ACUR) | 0.1 | $1.6M | 1.0M | 1.60 | |
| Threshold Pharmaceuticals | 0.1 | $1.5M | 2.2M | 0.68 | |
| Ocera Therapeutics | 0.1 | $1.5M | 573k | 2.64 | |
| Neos Therapeutics | 0.1 | $1.5M | 229k | 6.58 | |
| BioMarin Pharmaceutical (BMRN) | 0.1 | $1.3M | 14k | 92.54 | |
| Regeneron Pharmaceuticals (REGN) | 0.1 | $1.3M | 3.3k | 402.12 | |
| Teva Pharmaceutical Industries (TEVA) | 0.1 | $1.4M | 30k | 46.00 | |
| Streamline Health Solutions (STRM) | 0.1 | $1.2M | 663k | 1.84 | |
| Paratek Pharmaceuticals | 0.1 | $1.3M | 100k | 13.01 | |
| Clovis Oncology | 0.0 | $288k | 8.0k | 36.00 |
